Related Experiment Video
Updated: Jan 21, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Hypertension and Stroke: Update on Treatment.
Mauricio Wajngarten1, Gisele Sampaio Silva2,3
1Sao Paulo University Medical School Brazil.
Hypertension management is crucial for preventing and managing stroke, a leading cause of death and disability. This review covers blood pressure control for primary and secondary stroke prevention, including emergencies.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Stroke is a major global cause of death and disability.
- Hypertension is the primary modifiable risk factor for stroke.
- Heterogeneous stroke pathophysiology complicates blood pressure management.
Purpose of the Study:
- To provide an updated review on arterial hypertension management for stroke prevention.
- To discuss blood pressure management in hypertensive emergencies and acute stroke phases.
Main Methods:
- Literature review of hypertension management strategies.
- Analysis of blood pressure targets in acute stroke settings.
- Discussion of therapeutic goals in hypertensive urgencies and emergencies.
Main Results:
- Arterial hypertension requires precise management for primary and secondary stroke prevention.
- Specific blood pressure targets are necessary for different stroke types (ischemic, hemorrhagic) and hypertensive emergencies.
- Accurate diagnosis is key to effective therapeutic goal setting.
Conclusions:
- Effective hypertension control is essential for reducing stroke incidence and recurrence.
- Tailored blood pressure management strategies are vital in acute stroke and hypertensive emergencies.
- Further research into optimal blood pressure management in diverse stroke populations is warranted.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension I: Introduction

